TOI
The Oncology·NASDAQ
--
--(--)
--
--(--)
5.57 / 10
Netural
Liquidity flow is strong (7.67/10), indicating healthy fund inflows across block, small, medium, and large orders, despite a negative trend in each category. Analyst coverage is limited to one institution (Needham) but delivers a unanimous Strong Buy rating with a 100% historical win rate. This positive sentiment partially offsets weaker fundamentals and technicals, suggesting potential upside if flow momentum persists.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-25
InstitutionNeedham
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for TOI?
- TOI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.57/10 (Netural).
